UTS2 (Urotensin-II) is a somatostatin-like cyclic heptapeptide (Kim et al., 2017) and participates in the occurrence of different cancers, especially colon, breast, and prostate cancers (Giulianelli et al., 2019). Here, UTS2 is linked to cancer.